We are proud to announce the launch of the AltoStar® CMV PCR Kit 1.5 CAN. The availability of this product marks a big milestone in the reinforcement of the transplant & immunocompromised panel for our Canadian customers. CMV is probably the most prominent of the pathogens frequently tested for in transplant & immunocompromised patients. It complements our other HC licensed AltoStar® PCR kits in this panel such as products for the detection of Adenovirus, BKV, JCV, HHV-6, Parvovirus B19 and VZV, respectively.
The AltoStar® CMV PCR Kit 1.5 CAN is an in vitro diagnostic test, based on real-time PCR technology, for the quantification of human cytomegalovirus (CMV) specific DNA in human EDTA plasma. CMV is a human herpesvirus, which induces cytomegaly. While immunocompetent patients hardly present any symptoms, the virus poses a threat to immunocompromised patients due to opportunistic infections and viral reactivation. These patients may suffer from impaired function of the transplant or even loss of the organ. To prevent this, the viral load of CMV needs to be continuously monitored in these patients.
How to purchase the AltoStar® CMV PCR Kit 1.5 CAN kit? Contact the altona Diagnostics Canada team at canada@altona-diagnostics.com
More info about the AltoStar® CMV PCR Kit 1.5 CAN kit.
Our broad assay portfolio – Health Canada licenced.
altona Diagnostics GmbH
Mörkenstr. 12
22767 Hamburg, Germany